91��ɫ

About 91��ɫ Therapeutics

‍

91��ɫ Therapeutics is a clinical-stage biotech company advancing novel antigen modulation technology to guide the immune system. 91��ɫ approach modulates antigen presentation, flicking a switch inside cells to alter their appearance to the immune system. 91��ɫ are progressing first-in-class antigen modulators to treat people living with cancers, autoimmune disorders, and infectious diseases.

‍

91��ɫ is headquartered in Oxford, UK.

‍

More information: 91��ɫbsite |

‍

Media enquiries

Patrick White, Head of Communications

+44 (0)1235 644 970

patrick.white@gwt.bio

‍